Erik Stomrud

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz et al. · JAMA · 2020 · 1.4K citations · Full text

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton et al. · The Lancet Neurology · 2020 · 1.3K citations

Alzheimer's Disease, Dementia, Prospective Cohorts +11

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine · 2020 · 1.2K citations

Neurodegenerative Diseases, Plasma P-tau181, Alzheimer's Disease +14

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

Sebastian Palmqvist, Michael Schöll, Olof Strandberg et al. · Nature Communications · 2017 · 887 citations · Full text

CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Oskar Hansson, John Seibyl, Erik Stomrud et al. · Alzheimer s & Dementia · 2018 · 780 citations · Full text